Treatment of negative symptoms: Pharmacological and methodological issues

被引：39

作者：

Carpenter, WT ^{[1
]}

机构：

[1] MARYLAND PSYCHIAT RES CTR,CATONSVILLE,MD 21228

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1996年 / 168卷

关键词：

D O I：

10.1192/S0007125000298279

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：17 / 22

页数：6

共 44 条

[1] AN UN-DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].

ALPERT, M ;

FRIEDHOFF, AJ .

SCHIZOPHRENIA BULLETIN, 1980, 6 (03) :387-390

[2]

Andreasen N, 1984, SCALE ASSESSMENT POS

[3] EFFECT OF NEUROLEPTICS ON POSITIVE AND NEGATIVE SYMPTOMS AND THE DEFICIT STATE [J].

ANGST, J ;

STASSEN, HH ;

WOGGON, B .

PSYCHOPHARMACOLOGY, 1989, 99 :S41-S46

[4]

BORISON RL, 1992, PSYCHOPHARMACOL BULL, V28, P213

[5]

BREIER A, 1994, AM J PSYCHIAT, V151, P20

[6]

BUCHANAN R, 1996, NEW PHARMACOTHERAPY

[7] DOMAINS OF PSYCHOPATHOLOGY - AN APPROACH TO THE REDUCTION OF HETEROGENEITY IN SCHIZOPHRENIA [J].

BUCHANAN, RW ;

CARPENTER, WT .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (04) :193-204

[8]

BUCHANAN RW, 1993, AM J PSYCHIAT, V150, P59

[9]

BUCHANAN RW, 1990, AM J PSYCHIAT, V147, P290

[10] TREATMENT OF NEGATIVE SYMPTOMS [J].

CARPENTER, WT ;

HEINRICHS, DW ;

ALPHS, LD .

SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :440-452

← 1 2 3 4 5 →